These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 10460066

  • 1. Disposition kinetics and effects of menthol.
    Gelal A, Jacob P, Yu L, Benowitz NL.
    Clin Pharmacol Ther; 1999 Aug; 66(2):128-35. PubMed ID: 10460066
    [Abstract] [Full Text] [Related]

  • 2. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
    Kharasch ED, Hoffer C, Whittington D, Sheffels P.
    Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
    [Abstract] [Full Text] [Related]

  • 3. Human pharmacology of the methamphetamine stereoisomers.
    Mendelson J, Uemura N, Harris D, Nath RP, Fernandez E, Jacob P, Everhart ET, Jones RT.
    Clin Pharmacol Ther; 2006 Oct; 80(4):403-20. PubMed ID: 17015058
    [Abstract] [Full Text] [Related]

  • 4. Influence of menthol on caffeine disposition and pharmacodynamics in healthy female volunteers.
    Gelal A, Guven H, Balkan D, Artok L, Benowitz NL.
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):417-22. PubMed ID: 12915954
    [Abstract] [Full Text] [Related]

  • 5. Effect on bioavailability of admixing the contents of lansoprazole capsules with selected soft foods.
    Chun AH, Erdman K, Zhang Y, Achari R, Cavanaugh JH.
    Clin Ther; 2000 Feb; 22(2):231-6. PubMed ID: 10743982
    [Abstract] [Full Text] [Related]

  • 6. Relative bioavailability of tizanidine hydrochloride capsule formulation compared with capsule contents administered in applesauce: a single-dose, open-label, randomized, two-way, crossover study in fasted healthy adult subjects.
    Henney HR, Fitzpatrick A, Stewart J, Runyan JD.
    Clin Ther; 2008 Dec; 30(12):2263-71. PubMed ID: 19167586
    [Abstract] [Full Text] [Related]

  • 7. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T, Backman JT, Neuvonen M, Neuvonen PJ.
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [Abstract] [Full Text] [Related]

  • 8. Effects of cilomilast, a selective phosphodiesterase 4 inhibitor, on esophageal motility and pH, and orocecal and colonic transit: two single-center, randomized, double-blind, placebo-controlled, two-part crossover studies in healthy volunteers.
    Houghton LA, Atkinson W, Whorwell PJ, Morris J, Murdoch RD, Cooper SM, Webber DM, Walls CM.
    Clin Ther; 2006 Apr; 28(4):569-81. PubMed ID: 16750468
    [Abstract] [Full Text] [Related]

  • 9. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R, Rosillon D, Bridson WE, Meeus MA, Salas E, Stockis A.
    Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
    [Abstract] [Full Text] [Related]

  • 10. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
    Boonleang J, Panrat K, Tantana C, Krittathanmakul S, Jintapakorn W.
    Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
    [Abstract] [Full Text] [Related]

  • 11. The inhibition of bone resorption in rats treated with (-)-menthol is due to its metabolites.
    Spichiger M, Brenneisen R, Felix R, Mühlbauer RC.
    Planta Med; 2006 Nov; 72(14):1290-5. PubMed ID: 17021997
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM, van Vliet A, Abou Farha K, Cherrington JM, Campbell DA, Li X, Hanway D, Li J, Guler HP.
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [Abstract] [Full Text] [Related]

  • 13. Clinical pharmacology of 1,4-butanediol and gamma-hydroxybutyrate after oral 1,4-butanediol administration to healthy volunteers.
    Thai D, Dyer JE, Jacob P, Haller CA.
    Clin Pharmacol Ther; 2007 Feb; 81(2):178-84. PubMed ID: 17192771
    [Abstract] [Full Text] [Related]

  • 14. Hemodynamic effects of reboxetine in healthy male volunteers.
    Denolle T, Pellizzoni C, Jannuzzo MG, Poggesi I.
    Clin Pharmacol Ther; 1999 Sep; 66(3):282-7. PubMed ID: 10511064
    [Abstract] [Full Text] [Related]

  • 15. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
    Bittner B, Riek M, Holmes B, Grange S.
    Antivir Ther; 2005 Sep; 10(7):803-10. PubMed ID: 16312177
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
    Lim KS, Kim JR, Choi YJ, Shin KH, Kim KP, Hong JH, Cho JY, Shin HS, Yu KS, Shin SG, Kwon OH, Hwang DM, Kim JA, Jang IJ.
    Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
    [Abstract] [Full Text] [Related]

  • 17. Effect of menthol on the pharmacokinetics and pharmacodynamics of felodipine in healthy subjects.
    Gelal A, Balkan D, Ozzeybek D, Kaplan YC, Gurler S, Guven H, Benowitz NL.
    Eur J Clin Pharmacol; 2005 Jan; 60(11):785-90. PubMed ID: 15592925
    [Abstract] [Full Text] [Related]

  • 18. Absolute bioavailability of quinine formulations in Nigeria.
    Babalola CP, Bolaji OO, Ogunbona FA, Ezeomah E.
    Afr J Med Med Sci; 2004 Sep; 33(3):185-9. PubMed ID: 15819461
    [Abstract] [Full Text] [Related]

  • 19. Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
    Marbury TC, Jin B, Panebianco D, Murphy MG, Sun H, Evans JK, Han TH, Constanzer ML, Dru J, Shadle CR.
    Anesth Analg; 2009 Aug; 109(2):418-25. PubMed ID: 19608812
    [Abstract] [Full Text] [Related]

  • 20. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A.
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.